You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Discontinued ProductPam3CSK4 Biotin (Cat. No. 4636) has been withdrawn from sale for commercial reasons.
Biological Activity for Pam3CSK4 Biotin
Biotinylated Pam3CSK4 (Cat. No. 4633), a Toll-like receptor 1/2 agonist.
Technical Data for Pam3CSK4 Biotin
(Modifications: Cys = S-[2,3-Bis(palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl]-Cys, K6= aminocaproic acid-amonocaproic acid-biotin
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References for Pam3CSK4 Biotin
References are publications that support the biological activity of the product.
Marre et al (2010) Human integrin α3β1 regulates TLR2 recognition of lipopeptides from endosomal compartments. PLoS One 5 e12871 PMID: 20877569
View Related Products by Product Action
Keywords: Pam3CSK4 Biotin, Pam3CSK4 Biotin supplier, Pam3CSK4, Biotin, Toll-like, receptors, TLR1/2, agonists, Receptors, 4636, Tocris Bioscience
Citations for Pam3CSK4 Biotin
Citations are publications that use Tocris products.
Currently there are no citations for Pam3CSK4 Biotin.
Reviews for Pam3CSK4 Biotin
There are currently no reviews for this product. Be the first to review Pam3CSK4 Biotin and earn rewards!
Have you used Pam3CSK4 Biotin?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.